Advertisement
News
Subscribe to MDT Magazine News

The Lead

New Device Detects Deadly Lung Disease

July 24, 2014 | by University of Exeter | Comments

A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant...

TOPICS:

Tazca Connects and Telehealth International Partnership to Deploy Turnkey Telehealth Solutions for Disadvantaged Rural Areas

July 30, 2014 4:10 pm | Comments

Tazca Connects and Telehealth International Partnership (TIP) to deploy turnkey Telehealth solutions for disadvantaged rural areas worldwide based on affordable 4G LTE-as-a-Service. The partnership accelerates high quality healthcare by increasing rural community access to medical specialists.

TOPICS:

NSF grant to Wayne State supports new concept for manufacturing nanoscale devices

July 30, 2014 3:58 pm | Comments

According to the National Science Foundation, nanotechnology is the creation and utilization of functional materials, devices, and systems with novel properties and functions. A major bottleneck in scaling up nanotechnology is the lack of manufacturing methods that connect different functional materials into one device.

TOPICS:

Dissolvable fabric loaded with medicine might offer faster protection against HIV

July 30, 2014 3:49 pm | by EurekAlert! | Comments

University of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV. Their method spins the drug into silk-like fibers that quickly dissolve when in contact with moisture, releasing higher doses of the drug than possible with other topical materials such as gels or creams.

TOPICS:
Advertisement

Cold Genesys Raises $13.57 Million in a Series A Round of Financing to Accelerate Its Ongoing Phase II/III Clinical Trial for Bladder Cancer

July 30, 2014 3:38 pm | by The Associated Press | Comments

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Jul 30, 2014--Cold Genesys, Inc. (“CGI”), a clinical-stage biopharmaceutical company developing oncolytic immunotherapies for cancer, announced today that it has secured Series A financing of $13.57 million from Ally Bridge Group. CGI will deploy the capital...

Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer

July 30, 2014 1:37 pm | by PR Newswire | Comments

BOCA RATON, Fla., July 30, 2014 /PRNewswire/ -- Today the US Surgeon General issued the most stern warning to date for indoor and outdoor sun tanning or sun burns stating they can lead directly to deadly melanoma skin cancer. In his statement Surgeon, General Boris Lushniak,...

Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device

July 30, 2014 1:37 pm | by PR Newswire | Comments

SYRACUSE, N.Y., July 30, 2014 /PRNewswire-iReach/ -- Transluminal Technologies LLC, a Syracuse, NY-based medical device company, has announced today that they have received CE Mark approval for the velox CD™ Vascular Closure Device. Velox CD™ provides a safe and predictable...

Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market

July 30, 2014 11:41 am | by PR Newswire | Comments

BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the trend toward multimodality imaging, such as combining computed tomography and magnetic...

Brainwaves can predict audience reaction

July 30, 2014 11:30 am | by EurekAlert! | Comments

Media and marketing experts have long sought a reliable method of forecasting responses from the general population to future products and messages. According to a study conducted at The City College of New York, it appears that the brain responses of just a few individuals are a remarkably strong predictor. By analyzing the brainwaves of ...

TOPICS:
Advertisement

CD-adapco Helps Advance the use of Simulation in Medical Device Industry

July 30, 2014 11:12 am | Comments

CD-adapco announced its renewed membership with the Medical Device Innovation Consortium (MDIC), the first public-private partnership focused exclusively on the unique needs of the medical device community. MDIC made tremendous progress in the first year by bringing together the key players in the field of Computational Modeling and Simulation (CM&S). This momentum will drive

New Material For Surgical Products Could Aid In Healing Process

July 30, 2014 11:03 am | by McCormick School of Engineering and Applied Science | Comments

When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.

Researchers identify potential biomarker for AD

July 30, 2014 10:55 am | by EurekAlert! | Comments

Researchers from Boston University School of Medicine (BUSM) report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically. These findings appear in the Annals of Neurology.

App for headache sufferers shows success

July 30, 2014 10:21 am | by EurekAlert! | Comments

A unique app that helps headache sufferers to record the severity and regularity of their pain is being used as part of a Griffith research study. A new approach to the treatment of headaches, the ENHANCE project looks at coping with their triggers and is

TOPICS:

Wearable device for the early detection of common diabetes-related neurological condition

July 30, 2014 9:57 am | by EurekAlert! | Comments

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.

TOPICS:

Tigermed and Frontage Laboratories Complete Strategic Investment Agreement

July 30, 2014 9:35 am | by The Associated Press | Comments

EXTON, Pa.--(BUSINESS WIRE)--Jul 30, 2014--Hangzhou Tigermed Consulting Co., Ltd. and Frontage Laboratories, Inc. today announced completion of the previously announced investment agreement, following approval by the China Securities and Regulatory Commission. Tigermed, a leading provider of...

BIOLASE Sends Letter to Stockholders

July 30, 2014 9:35 am | by The Associated Press | Comments

IRVINE, Calif.--(BUSINESS WIRE)--Jul 30, 2014--BIOLASE, Inc. (NASDAQ:BIOL), the world’s leading dental laser manufacturer and distributor, today sent a letter to its stockholders. The full text of the letter from the majority of the Board to stockholders is below: To Our Fellow...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading